Catalyst Wire Dossier Catalyst Wire Dossier

METHOCARBAMOL TABLETS, USP, 500 MG

methocarbamol · Marlex Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for METHOCARBAMOL TABLETS, USP, 500 MG, covering 2021-04-30 to 2021-04-30. Get the full timeline:

Most recent: FDA Approved: METHOCARBAMOL TABLETS, USP, 500 MG — Original Application (Marlex Pharmaceuticals, Inc.)

See pricing